Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings Of The Fortnight: Do Larger Series A Rounds Mean Less Successful Exits?

This article was originally published in The Pink Sheet Daily

Executive Summary

A five-year review of Series A financings finds no negative correlation between the size of an A round and the likelihood of an investor exit. Plus news on recent financings by Veracyte, Calithera Biosciences, Spark Therapeutics and Versant Ventures.


Related Content

CHOP Commits $50 Million To Gene Therapy Spin-Out Spark Therapeutics
With Precedents In Place, GenSight Eyes Gene Therapies For Orphan Disorders
Veracyte: How To Build A Molecular Cytology Company
Roche Enters Hearing-Loss Space In Risk-Sharing Venture With Inception, Versant
Life Sciences VCs Leave Morgenthaler, ATV To Form New Fund
UCSF Spinout Calithera Biosciences Takes $40 Million First Round


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts